Cargando…

Surgical Challenges in Infective Endocarditis: State of the Art

Infective endocarditis (IE) is still a life-threatening disease with frequent lethal outcomes despite the profound changes in its clinical, microbiological, imaging, and therapeutic profiles. Nowadays, the scenario for IE has changed since rheumatic fever has declined, but on the other hand, multipl...

Descripción completa

Detalles Bibliográficos
Autores principales: Iaccarino, Alessandra, Barbone, Alessandro, Basciu, Alessio, Cuko, Enea, Droandi, Ginevra, Galbiati, Denise, Romano, Giorgio, Citterio, Enrico, Fumero, Andrea, Scarfò, Iside, Manzo, Rossella, La Canna, Giovanni, Torracca, Lucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532218/
https://www.ncbi.nlm.nih.gov/pubmed/37762834
http://dx.doi.org/10.3390/jcm12185891
_version_ 1785111904194134016
author Iaccarino, Alessandra
Barbone, Alessandro
Basciu, Alessio
Cuko, Enea
Droandi, Ginevra
Galbiati, Denise
Romano, Giorgio
Citterio, Enrico
Fumero, Andrea
Scarfò, Iside
Manzo, Rossella
La Canna, Giovanni
Torracca, Lucia
author_facet Iaccarino, Alessandra
Barbone, Alessandro
Basciu, Alessio
Cuko, Enea
Droandi, Ginevra
Galbiati, Denise
Romano, Giorgio
Citterio, Enrico
Fumero, Andrea
Scarfò, Iside
Manzo, Rossella
La Canna, Giovanni
Torracca, Lucia
author_sort Iaccarino, Alessandra
collection PubMed
description Infective endocarditis (IE) is still a life-threatening disease with frequent lethal outcomes despite the profound changes in its clinical, microbiological, imaging, and therapeutic profiles. Nowadays, the scenario for IE has changed since rheumatic fever has declined, but on the other hand, multiple aspects, such as elderly populations, cardiovascular device implantation procedures, and better use of multiple imaging modalities and multidisciplinary care, have increased, leading to escalations in diagnosis. Since the ESC and AHA Guidelines have been released, specific aspects of diagnostic and therapeutic management have been clarified to provide better and faster diagnosis and prognosis. Surgical treatment is required in approximately half of patients with IE in order to avoid progressive heart failure, irreversible structural damage in the case of uncontrolled infection, and the prevention of embolism. The timing of surgery has been one of the main aspects discussed, identifying cases in which surgery needs to be performed on an emergency (within 24 h) or urgent (within 7 days) basis, irrespective of the duration of antibiotic treatment, or cases where surgery can be postponed to allow a brief period of antibiotic treatment under careful clinical and echocardiographic observation. Mainly, guidelines put emphasis on the importance of an endocarditis team in the handling of systemic complications and how they affect the timing of surgery and perioperative management. Neurological complications, acute renal failure, splenic or musculoskeletal manifestations, or infections determined by multiresistant microorganisms or fungi can affect long-term prognosis and survival. Not to be outdone, anatomical and surgical factors, such as the presence of native or prosthetic valve endocarditis, a repair strategy when feasible, anatomical extension and disruption in the case of an annular abscess (mitral valve annulus, aortic mitral curtain, aortic root, and annulus), and the choice of prosthesis and conduits, can be equally crucial. It can be hard for surgeons to maneuver between correct pre-operative planning and facing unexpected obstacles during intraoperative management. The aim of this review is to provide an overview and analysis of a broad spectrum of specific surgical scenarios and how their challenging management can be essential to ensure better outcomes and prognoses.
format Online
Article
Text
id pubmed-10532218
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105322182023-09-28 Surgical Challenges in Infective Endocarditis: State of the Art Iaccarino, Alessandra Barbone, Alessandro Basciu, Alessio Cuko, Enea Droandi, Ginevra Galbiati, Denise Romano, Giorgio Citterio, Enrico Fumero, Andrea Scarfò, Iside Manzo, Rossella La Canna, Giovanni Torracca, Lucia J Clin Med Review Infective endocarditis (IE) is still a life-threatening disease with frequent lethal outcomes despite the profound changes in its clinical, microbiological, imaging, and therapeutic profiles. Nowadays, the scenario for IE has changed since rheumatic fever has declined, but on the other hand, multiple aspects, such as elderly populations, cardiovascular device implantation procedures, and better use of multiple imaging modalities and multidisciplinary care, have increased, leading to escalations in diagnosis. Since the ESC and AHA Guidelines have been released, specific aspects of diagnostic and therapeutic management have been clarified to provide better and faster diagnosis and prognosis. Surgical treatment is required in approximately half of patients with IE in order to avoid progressive heart failure, irreversible structural damage in the case of uncontrolled infection, and the prevention of embolism. The timing of surgery has been one of the main aspects discussed, identifying cases in which surgery needs to be performed on an emergency (within 24 h) or urgent (within 7 days) basis, irrespective of the duration of antibiotic treatment, or cases where surgery can be postponed to allow a brief period of antibiotic treatment under careful clinical and echocardiographic observation. Mainly, guidelines put emphasis on the importance of an endocarditis team in the handling of systemic complications and how they affect the timing of surgery and perioperative management. Neurological complications, acute renal failure, splenic or musculoskeletal manifestations, or infections determined by multiresistant microorganisms or fungi can affect long-term prognosis and survival. Not to be outdone, anatomical and surgical factors, such as the presence of native or prosthetic valve endocarditis, a repair strategy when feasible, anatomical extension and disruption in the case of an annular abscess (mitral valve annulus, aortic mitral curtain, aortic root, and annulus), and the choice of prosthesis and conduits, can be equally crucial. It can be hard for surgeons to maneuver between correct pre-operative planning and facing unexpected obstacles during intraoperative management. The aim of this review is to provide an overview and analysis of a broad spectrum of specific surgical scenarios and how their challenging management can be essential to ensure better outcomes and prognoses. MDPI 2023-09-11 /pmc/articles/PMC10532218/ /pubmed/37762834 http://dx.doi.org/10.3390/jcm12185891 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Iaccarino, Alessandra
Barbone, Alessandro
Basciu, Alessio
Cuko, Enea
Droandi, Ginevra
Galbiati, Denise
Romano, Giorgio
Citterio, Enrico
Fumero, Andrea
Scarfò, Iside
Manzo, Rossella
La Canna, Giovanni
Torracca, Lucia
Surgical Challenges in Infective Endocarditis: State of the Art
title Surgical Challenges in Infective Endocarditis: State of the Art
title_full Surgical Challenges in Infective Endocarditis: State of the Art
title_fullStr Surgical Challenges in Infective Endocarditis: State of the Art
title_full_unstemmed Surgical Challenges in Infective Endocarditis: State of the Art
title_short Surgical Challenges in Infective Endocarditis: State of the Art
title_sort surgical challenges in infective endocarditis: state of the art
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532218/
https://www.ncbi.nlm.nih.gov/pubmed/37762834
http://dx.doi.org/10.3390/jcm12185891
work_keys_str_mv AT iaccarinoalessandra surgicalchallengesininfectiveendocarditisstateoftheart
AT barbonealessandro surgicalchallengesininfectiveendocarditisstateoftheart
AT basciualessio surgicalchallengesininfectiveendocarditisstateoftheart
AT cukoenea surgicalchallengesininfectiveendocarditisstateoftheart
AT droandiginevra surgicalchallengesininfectiveendocarditisstateoftheart
AT galbiatidenise surgicalchallengesininfectiveendocarditisstateoftheart
AT romanogiorgio surgicalchallengesininfectiveendocarditisstateoftheart
AT citterioenrico surgicalchallengesininfectiveendocarditisstateoftheart
AT fumeroandrea surgicalchallengesininfectiveendocarditisstateoftheart
AT scarfoiside surgicalchallengesininfectiveendocarditisstateoftheart
AT manzorossella surgicalchallengesininfectiveendocarditisstateoftheart
AT lacannagiovanni surgicalchallengesininfectiveendocarditisstateoftheart
AT torraccalucia surgicalchallengesininfectiveendocarditisstateoftheart